Cite
HARVARD Citation
Yang, M. et al. (2022). Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan. European journal of heart failure. pp. 2307-2319. [Online].